- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: December 2017
- Public Summary Document (PSD) December 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) December 2017 PBAC Meeting - Word
Fluticasone furoate with umeclidinium and vilanterol – December 2017
Fluticasone furoate with umeclidinium and vilanterol: Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per
Last updated
9 November 2018
